Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
7.10
+0.16 (2.31%)
Aug 20, 2026, 3:04 PM CST

SHE:002550 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
354.96491.05439.95576.23409.26617.81
Short-Term Investments
84.6176.2192.964.95--
Trading Asset Securities
787.46594.02273.8371.9867.4868.23
Cash & Short-Term Investments
1,2271,161906.67713.16476.73686.03
Cash Growth
20.44%28.08%27.13%49.59%-30.51%-8.58%
Accounts Receivable
265.84299.1274.25275.52632.87447.67
Other Receivables
18.3918.9423.2416.92.482.56
Receivables
284.24318.04297.48292.42635.35450.23
Inventory
405.19372.44426.81602.01536.48400.63
Prepaid Expenses
-----0.01
Other Current Assets
82.3756.6762.7318.3938.7233.04
Total Current Assets
1,9991,9081,6941,6261,6871,570
Property, Plant & Equipment
693.27681.93563.6561.27616.39611.77
Long-Term Investments
50.88134.16160.08203.22156.7840.56
Goodwill
11.1411.1411.1411.1411.1411.14
Other Intangible Assets
105.57107.21109.32113.14100.86106.92
Long-Term Deferred Tax Assets
69.8266.5275.2690.53101.4999.42
Long-Term Deferred Charges
192.39173.03138.0493.7760.3346.85
Other Long-Term Assets
6.474.4715.33.0571.6721.81
Total Assets
3,1283,0872,8302,7662,8062,508

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
84.3577.5188.6441.1845.9771.23
Accrued Expenses
158.28125.688.0689.7101.9499.55
Short-Term Debt
30.950.2721.4956.31103.0593.56
Current Income Taxes Payable
9.640.441.530.640.05-
Current Unearned Revenue
3.37.649.689.7115.5819.67
Other Current Liabilities
12.7912.75148.2811.6312.34
Total Current Liabilities
299.3224.21223.39205.81278.22296.35
Long-Term Leases
3.123.07----
Long-Term Unearned Revenue
94.6188.5886.4681.8589.3593.42
Long-Term Deferred Tax Liabilities
4.694.784.024.524.960.47
Total Liabilities
401.72320.64313.87292.17372.53390.24

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,2801,2801,2801,2801,2801,280
Additional Paid-In Capital
34.3741.4241.6541.6536.2929.38
Retained Earnings
1,5821,6181,3691,1631,134960.89
Treasury Stock
-156.88-170.86-170.86-30.09--145.05
Comprehensive Income & Other
-0.69-0.55-2.420.36-0.062.23
Total Common Equity
2,7382,7682,5172,4552,4502,127
Minority Interest
-11.62-1.68-0.8718.98-16.95-9.09
Shareholders' Equity
2,7272,7662,5172,4742,4332,118
Total Liabilities & Equity
3,1283,0872,8302,7662,8062,508

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
34.073.3421.4956.31103.0593.56
Net Cash (Debt)
1,1931,158885.19656.85373.69592.48
Net Cash Growth
19.41%30.81%34.76%75.78%-36.93%-16.38%
Net Cash Per Share
0.950.930.700.510.290.49
Filing Date Shares Outstanding
1,2611,2501,2501,2751,2801,280
Total Common Shares Outstanding
1,2611,2501,2501,2751,2801,280
Working Capital
1,7001,6841,4701,4201,4091,274
Book Value Per Share
2.172.212.011.931.911.66
Tangible Book Value
2,6222,6502,3972,3312,3382,009
Tangible Book Value Per Share
2.082.121.921.831.831.57
Buildings
568.25568.23498.75498.75525.73524.28
Machinery
628.88624.66568.44558.3504.84461.29
Construction In Progress
150.32110.3961.258.1954.139.24